Polymorphisms in tumour necrosis factor alpha (TNFalpha) gene in patients with acute pancreatitis.
Proinflammatory cytokines, such as tumour necrosis factor alpha (TNFalpha), play fundamental roles in the pathogenesis of acute pancreatitis (AP). The aim of this study was to determine if polymorphisms in the TNFalpha gene are associated with AP. Two polymorphisms located in the promoter region (positions -308 and -238) in TNFalpha gene were determined using polymerase chain reaction- (PCR-) restriction fragment length polymorphism (RFLP) methods in 103 patients with AP and 92 healthy controls. Odds ratios (ORs) and 95% confidence intervals (CI) were estimated using logistic regression analysis adjusted for age, sex, BMI and smoking. The frequencies of TNFalpha polymorphisms were both similar in patients with mild or severe pancreatitis, so were in pancreatitis patients and in controls. We suggest that both SNPs of TNFalpha are not genetic risk factor for AP susceptibility (OR = 1.63; 95% CI: 1.13-4.01 for TNFalpha(-308) and OR = 0.86; 95% CI: 0.75-1.77 for TNFalpha(-238)).
Ozhan
Gül
G
Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Istanbul University, 34116 Istanbul, Turkey.
Yanar
Hakan T
HT
Ertekin
Cemalettin
C
Alpertunga
Buket
B
D000208:Acute Disease; D000328:Adult; D000368:Aged; D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D008297:Male; D008875:Middle Aged; D010195:Pancreatitis / Q000235:genetics* / Q000276:immunology; D011110:Polymorphism, Genetic; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics*
D014409:Tumor Necrosis Factor-alpha
Cancer. 1997 Oct 15;80(8):1489-96
9338474
J Surg Res. 2003 Jun 15;112(2):138-43
12888330
Mol Cancer Res. 2006 Apr;4(4):221-33
16603636
Pancreas. 2005 May;30(4):333-6
15841043
Crit Care Clin. 1995 Apr;11(2):295-309
7788533
Methods Enzymol. 1996;272:199-210
8791778
Genet Med. 2003 Mar-Apr;5(2):120-5
12644782
J Clin Invest. 2007 Jan;117(1):50-9
17200706
Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):726-31
16614115
Arch Surg. 1993 May;128(5):586-90
8489394
Surgery. 1996 Sep;120(3):515-21
8784406
Eur Cytokine Netw. 2007 Mar;18(1):31-7
17400536
Am J Physiol. 1997 Sep;273(3 Pt 1):G696-705
9316474
Endocrinol Metab Clin North Am. 2006 Jun;35(2):289-302, viii-ix
16632093
Pancreas. 2003 May;26(4):339-43
12717265
JOP. 2006 Jan 11;7(1):14-26
16407614
Arch Surg. 1995 Sep;130(9):966-70
7661681
Eur J Gastroenterol Hepatol. 2003 Nov;15(11):1223-7
14560157
Biochem Biophys Res Commun. 1999 Nov 19;265(2):545-9
10558906
Surgery. 2001 May;129(5):633-40
11331456
Br J Surg. 1995 Jan;82(1):6-13
7881958
JAMA. 1999 Aug 11;282(6):561-8
10450718
Obes Surg. 2008 Sep;18(9):1183-7
18563497
Arch Intern Med. 2009 Jun 8;169(11):1035-45
19506173
JOP. 2000 Jul;1(2):24-35
11852287
Proc Natl Acad Sci U S A. 1986 Nov;83(22):8699-702
3464978
Clin Chem. 2008 Jan;54(1):131-8
17981921
Immunogenetics. 1994;39(2):150-4
7903959
Gastroenterology. 2007 Apr;132(4):1557-73
17466744
N Engl J Med. 1993 May 20;328(20):1433-7
8479461
Lancet. 2001 Feb 17;357(9255):539-45
11229684
Gynecol Endocrinol. 2004 Jan;18(1):47-9
15106365
Cell Res. 2005 Jan;15(1):72-7
15686632
Br J Surg. 1996 Mar;83(3):349-53
8665189
Hum Mol Genet. 1992 Aug;1(5):353
1363876
Br J Surg. 2008 Jan;95(1):22-32
18076020
Pancreatology. 2005;5(6):514-29
16110250
Arch Intern Med. 2009 Mar 23;169(6):603-9
19307524
Br J Surg. 1999 Oct;86(10):1302-5
10540138
Pancreas. 2005 Mar;30(2):e46-50
15714129
Am J Hum Genet. 1996 Sep;59(3):676-83
8751869
Surgery. 1994 Feb;115(2):213-21
8310410
Am J Surg. 1998 Jan;175(1):76-83
9445247
Pancreatology. 2008;8(1):63-70
18235217
Am Surg. 1996 Jan;62(1):8-13
8540653